Fresenius Kabi USA, LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$9.8M
Doctors Paid
8,974
Transactions
22,091
2024 Total
$1.5M
Payment Breakdown by Category
Research$4.4M (45.0%)
Royalty/License$2.1M (21.8%)
Consulting$1.8M (18.3%)
Food & Beverage$512,766 (5.2%)
Travel$465,440 (4.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.4M | 410 | 45.0% |
| Royalty or License | $2.1M | 9 | 21.8% |
| Consulting Fee | $1.8M | 844 | 18.3% |
| Food and Beverage | $512,766 | 19,669 | 5.2% |
| Travel and Lodging | $465,440 | 959 | 4.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $191,484 | 74 | 1.9% |
| Honoraria | $122,556 | 53 | 1.2% |
| Space rental or facility fees (teaching hospital only) | $110,288 | 35 | 1.1% |
| Education | $42,980 | 16 | 0.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $15,480 | 15 | 0.2% |
| Charitable Contribution | $1,500 | 2 | 0.0% |
| Entertainment | $504.17 | 3 | 0.0% |
| Gift | $89.99 | 2 | 0.0% |
Payments by Type
General
$5.4M
21,681 transactions
Research
$4.4M
410 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Multicenter, Prospective, Controlled, Longitudinal-Cohort Study Assessing the Safety of Omegaven in Pediatric Patients with Parenteral Nutrition-Associated Cholestasis (PNAC) | $669,332 | 0 | 30 |
| Blood Center of Wisconsin | $426,970 | 0 | 36 |
| BCW Sponsored Master Agreement | $400,000 | 0 | 2 |
| SMOF-018-CP3 | $370,599 | 0 | 62 |
| In Vitro and In Vivo Evaluation of an Alternate Filter for the Alyx A200 Leukoreduction Filter | $283,198 | 0 | 6 |
| ARC Sponsored Master Agreement | $221,807 | 0 | 4 |
| Optimizing Recover in Trauma Patients: Integrating Enhanced Nutrition Delivery with Muscle Assessments, Functional Outcomes and Quality of Life | $162,000 | 0 | 2 |
| OMEG-035-IP3 | $150,229 | 0 | 3 |
| Univ of Cin study | $142,507 | 0 | 1 |
| Baylor College of Medicine-1 | $112,140 | 0 | 2 |
| Impact of SMOFlipid on Clinical Outcomes Among Patients Receiving Parenteral Nutrition | $94,000 | 0 | 1 |
| Boston Children | $92,517 | 0 | 1 |
| Cleveland Clinic Foundation | $73,450 | 0 | 2 |
| Duke University | $69,538 | 0 | 2 |
| SMOF-018-Walsh | $65,031 | 0 | 8 |
| HE06-019-IP4 | $65,000 | 0 | 1 |
| BCW Photopheresis Protocol | $64,570 | 0 | 2 |
| SMOF-018-Mascarenhas | $64,440 | 0 | 22 |
| ALYX-001-CMD / In Vitro and In Vivo Evaluation of an Alternate Filter for the ALYX A200 Leukoreduction Filter | $60,190 | 0 | 1 |
| SMOF-028-CP4 | $53,811 | 0 | 9 |
| SMOF-018-Robinson | $45,395 | 0 | 6 |
| Baylor College of Medicine-2 | $42,186 | 0 | 1 |
| SMOF-018-Ling | $41,191 | 0 | 12 |
| Effects of single and combined supplementation of glutamine and n-3 PUFAs on sepsis | $40,000 | 0 | 1 |
| Children's Hospital of Philadelphia | $38,814 | 0 | 19 |
| Duke IRB Pro102602 | $34,400 | 0 | 2 |
| Study Agreement Phoenix Children's | $29,961 | 0 | 1 |
| Evaluation of the Aurora Xi New Nomogram Software 2.0 | $27,200 | 1 | 7 |
| SMOF-018-Shores | $26,614 | 0 | 8 |
| American Red Cross | $26,157 | 0 | 4 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Dr. Thomas Gniadek, Md Phd, MD PHD | Blood Banking & Transfusion Medicine | Saint Louis, MO | $21,363 | $0 |
| Dr. William Mitch, M.d, M.D | Internal Medicine | Houston, TX | $20,366 | $0 |
| Sadeq Quraishi, M.d, M.D | Anesthesiology | Boston, MA | $19,536 | $0 |
| Dr. Ralph Vassallo, Md, MD | Hematology | Philadelphia, PA | $17,864 | $0 |
| Dr. David Waterhouse, Md, MD | Hematology & Oncology | Cincinnati, OH | $17,221 | $0 |
| Keith Berge, M.d, M.D | Anesthesiology | Rochester, MN | $15,728 | $0 |
| Robert Rifkin, Md, MD | Hematology & Oncology | Denver, CO | $14,173 | $0 |
| Mrs. Merin Kinikini, N.p, N.P | Nurse Practitioner | Salt Lake City, UT | $14,084 | $0 |
| Dr. Jami Kinnucan, M.d, M.D | Internal Medicine | Jacksonville, FL | $13,469 | $0 |
| Ms. Kara Calkins, M.d, M.D | Pediatrics | Los Angeles, CA | $13,455 | $0 |
| Fadi Braiteh, M.d, M.D | Internal Medicine | Las Vegas, NV | $12,918 | $0 |
| Jason Crane, D.o, D.O | Blood Banking & Transfusion Medicine | Rosemont, IL | $12,000 | $0 |
| Dr. Sahir Kalim | Nephrology | Boston, MA | $11,947 | $0 |
| Alfonso Bello, Md, MD | Rheumatology | Glenview, IL | $11,924 | $0 |
| Matthew Weinger, Md, MD | Anesthesiology | Nashville, TN | $11,738 | $0 |
| Bradley Yoder | Neonatal-Perinatal Medicine | Salt Lake City, UT | $11,631 | $0 |
| Sylvia Richey, Md, MD | Hematology & Oncology | Germantown, TN | $10,720 | $0 |
| Dr. Daniel Robinson, Md, MD | Neonatal-Perinatal Medicine | Chicago, IL | $10,641 | $0 |
| Dr. Debora Duro, Md, Ms, MD, MS | Pediatrics | Fort Lauderdale, FL | $10,563 | $0 |
| Pamela Flood, Md, MD | Anesthesiology | Stanford, CA | $10,289 | $0 |
| Dr. Lawrence Tanenbaum, M.d, M.D | Diagnostic Radiology | New York, NY | $10,075 | $0 |
| Rafael Barrera, Md, MD | Surgery | New Hyde Park, NY | $9,971 | $0 |
| Dr. Jayshil Patel, M.d, M.D | Internal Medicine | Milwaukee, WI | $9,705 | $0 |
| Dr. Rodney Daniel, Md Mscr, MD MSCR | Rheumatology | Oldsmar, FL | $9,062 | $0 |
| David Friedman, M.d, M.D | Pediatrics | Philadelphia, PA | $8,973 | $0 |
Ad
Top Products
- OMEGAVEN $2.8M
- Smoflipid $1.5M
Associated Products (25)
- OMEGAVEN $2.8M
- Smoflipid $1.5M
- Amicus $940,619
- IDACIO $379,391
- MD-Other $362,272
- Omegaven $313,439
- PH-Omegaven $276,909
- SMOFLIPID $180,103
- Stimufend $112,082
- MD-Amicus $92,859
- Volume Therapy $86,456
- Amicus Separator $74,991
- PH-Icatibant $64,767
- Alyx Component Collection System $62,440
- PH-Smoflipid $49,545
- CATSmart $41,554
- Dilaudid $41,372
- Ketoanalogues $33,312
- Sodium Chloride $31,291
- Vitamin A $20,346
- Ivenix Infusion System $15,228
- SMOFLIPID 20% 100 G 500ML BAG $15,000
- Diphenhydramine $12,177
- Platelet Additive Solution $11,892
- Ketosteril $10,933
Payment Categories
- Food & Beverage $512,766
- Consulting $1.8M
- Travel & Lodging $465,440
- Research $4.4M
- Royalties $2.1M
About Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC has made $9.8M in payments to 8,974 healthcare providers, recorded across 22,091 transactions in the CMS Open Payments database. In 2024, the company paid $1.5M. The top product by payment volume is OMEGAVEN ($2.8M).
Payments were distributed across 159 medical specialties. The top specialty by payment amount is Blood Banking & Transfusion Medicine ($415,646 to 31 doctors).
Payment categories include: Food & Beverage ($512,766), Consulting ($1.8M), Research ($4.4M), Travel & Lodging ($465,440), Royalties ($2.1M).
Fresenius Kabi USA, LLC is associated with 25 products in the CMS Open Payments database, including OMEGAVEN, Smoflipid, and Amicus.